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Herewith, we report on a method that allows to simultaneously protect both the Δ14,15 bond and the carbonyl
group of the symmetrical bis-steroidal diketone 2. We found that environmentally friendly and gas-free chlori-
nation is ideally suited to achieve this goal. This method was discovered during our efforts to methoxylate 2 in a
solution of dichloromethane and basic methanol in the presence of diacetoxy iodobenzene. Unexpectedly, the
Δ14,15 bonds were chlorinated once as well as twice in a statistical manner. Interestingly, the singly dichlorinated
desymmetrized product is an ideal precursor for conduction a series of position selective transformations.
Importantly, the carbonyl group present in the nonchlorinated hemisphere can be selectively reduced, olefinated
or oximated, while the other carbonyl group stays unaltered. A structurally related “monomeric” steroid deriv-
ative undergoes Δ14,15 chlorination and 11-position methoxylation under same conditions. These findings
represent a powerful entry for preparing new nonsymmetrical cephalostatin derivatives.1. Introduction
The highly antitumor active natural product cephalostatin 1 1 (Figure
1) which was isolated from the marine worm Cephalodiscus gilchristi
among 18 other compounds by the Pettit group has attracted much
attention [1, 2, 3, 4]. These metabolites show a unique cytotoxicity
profile in in vitro screenings that were conducted at the National Cancer
Institute. Indeed, cephalostatin 1 is an extremely powerful agent that acts
via a unique apoptosis pathway [5] which was also found by us or an
analogue [6]. The first total synthesis of cephalostatin 1 1 and several
other natural analogues from the same family were reported by Fuchs et
al. [7] Later, Shair and coworkers disclosed the second total synthesis of
cephalostatin 1 1 [8]. Both synthetic routes are rather lengthy and relied
on the unsymmetrical coupling of both steroidal parts. Winterfeldt and
coworkers, however, pursued synthetic approaches based on both sym-
metrical as well as unsymmetrical approaches [9, 10]. These were based
on the synthesis of symmetrical bis-steroidal diketone 2 (Figure 2) fol-
lowed by selective desymmetrization. The starting material 2 was pre-
pared by our group in gram scale in a straightforward manner [11].
Desymmetrization of the dimer includes three routes: First, selectiveh@yahoo.com (M. Nawasreh).
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is an open access article under treduction of the carbonyl group [9, 12]. Secondly, selective ring opening
of the spiroketal moiety [13, 14, 15] and thirdly, regioselective hydro-
boration of both the exocyclic Δ12,28 bond and the Δ14,15 bond of selected
dimers (analogues 3A and 3B; Figure 3) [16, 17].
In this work, we disclose the chlorination of the Δ14,15 bond in an
unconventional manner in order to mask both the double bond and the
carbonyl group. This unprecedented chlorination method of the Δ14,15
bond was discovered when using the mild oxidizing agent diacetoxy
iodosobenzene in a solvent system consisting of basic methanol and
dichloromethane.
2. Results and discussion
Over the last two decades, we concentrated our efforts on the prep-
aration of new cephalostatin analogues starting from the readily avail-
able diketone 2 [9]. The discovery of chemoselective reactions that
address only one hemisphere of the symmetrical diketone is of great
importance either for the synthesis of new derivatives, that mimic the
nonsymmetric cephalostatin 1 1. Therefore, we pursued to utilize
multipurpose directing groups. Hence, by treating a solution of 2 in6 December 2019
he CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Structure of cephalostatin 1.


























































































































iv) Bis-methoxylated diketone (analogue 3D).
Figure 3. Selected analogues derived from the diketone 2.
M. Nawasreh et al. Heliyon 6 (2020) e03025dichloromethane with diacetoxy iodobenzene in a solution of KOH/-
MeOH at temperatures between 0-10 C provided the desired
11α-methoxy diketone 3C and its symmetrical byproduct 3D (Figure 3)
[12]. However, adding a solution of 2 in undistilled dichloromethane to
KOH/MeOH solution at 0 C followed by the addition of diacetoxy
iodobenzene and conducting the reaction at 0 C for 2 h provided a
different major product.
Mass spectrometry (FABS) of the major product showed a main peak
at 917 with 71 units heavier compared to the starting material 2. How-
ever, analysis of the 1H NMR spectrum of this compound revealed that
one signal of the Δ14,15 bonds had disappeared and a new singlet reso-
nating at δ 4.62 ppm besides a doublet resonating at δ 4.46 ppm (J ¼ 6.6
Hz) occurred. The sharp singlet resonating at δ 4.62 ppm indicates no
coupling is visible with the neighbouring proton. The 13C-NMR spectrum
revealed two signals at δ 210.7 and 209.1 ppm that corresponds to two
carbonyl groups. In addition, a strongly deshielded sp [3]-hybridized
quaternary carbon atom resonates at δ 90.0 ppm. Despite all these data
and 2D-NMR-, IR-, MS- (ESI, HR-ESI) measurements the unequivocal
structure elucidation was not possible. Firstly, we reckoned that a
multi-oxygenated product was formed which may have resulted from an
unknown reaction between the Δ14,15 bond and diacetoxy iodoso-
benzene. Chemically, this new product showed high resistance towards
acetylation and under acidic hydrolysis conditions no transformation was
observed. This valuable information suggested the absence of free hy-
droxyl groups or the presence of an acetal moiety. Moreover, sodium
borohydride reduction led to the reduction of only one carbonyl group.
This is a very important result, since it suggests that the new functional
group in the former double bond region blocks the neighboring keto
group. All attempts to collect crystals failed. However, we were satisfied
to crystallize product 6 which resulted from the reduction of the new
derivative with NaBH4. X-ray crystallographic analysis revealed
(Figure 4) that two chlorine atoms were present likely bound at the site of
the former Δ14,15 bond and the relative orientation of the 14,15-dichloro
derivative 4 (see Figure 5) was trans (Scheme 1). Interestingly, no
coupling between 15-H (singlet, δ 4.62 ppm) and 16-H (doublet, δ 4.46
ppm) was observed in the COSY as well as ROESY spectra. Obviously,
these protons are oriented towards each other in a dihedral angle around2
90 which agrees with the crystallographic data. These results raise the
question of a possible mechanism (see Scheme 2).
In Scheme 2, the possible mechanistic routes of chlorination are
summarized. To gain information on the source of chlorine in the
resulting product, two hypotheses were examined. Either, the solvent
dichloromethane could be the source. The second hypothesis is based on
the fact that dichloromethane contains traces of HCl which could be an
alternative source for chlorine under the given conditions. We conducted
several experiments to verify which hypotheses/route is the reasonable
one (Scheme 2).
The first hypothesis follows the idea that the chlorinating agent is
generated by the reaction of dichloromethane with diacetoxy iodo-
benzene in the presence of methanol under basic conditions. The possible
substitution of one chloride with methoxy leads to intermediate A and Cl-
ion which in turn can substitute the acetate group(s) in PhI(OAc)2. As a
consequence, PhI(OAc)Cl (reagent A1, Scheme 2), which may be the
reagent of chlorination (Route 1), and finally PhICl2 (reagent A2) would
be formed. Still, PhICl2 can undergo reductive elimination to form
iodobenzene and Cl2 which then adds to the olefinic double bond to yield
the dichloro adduct (Scheme 2, Route 2). Moreover, PhICl2 may be added
to the alkene forming the intermediate B and then decomposes to PhI and
Cl-ion which in turn attacks the chloronium intermediate C (Scheme 2,
Route 3). The other possibility is the formation of Cl2 from the oxidation
of Cl-ion with PhI(OAc)2 (Scheme 2, Route 4).
Figure 4. X-Ray molecular structure of 6.
Scheme 1. Chlorination of the symmetrical diketone 2.
M. Nawasreh et al. Heliyon 6 (2020) e03025Following an alternative procedure, a solution of diketone 2 at 0 C
was treated with 1.5 eq of a freshly prepared PhICl2 at rt which was
prepared from PhI and 5% of a bleach solution [18]. This initiated a
chlorination reaction in less than 30min yielding compounds 4 and 5 in a
statistical ratio along with some other byproducts. This relatively fast
reaction can be followed by TLC. Moreover, one cannot exclude the
possibility of Cl oxidation by PhI(OAc)2 to form Cl2 as reported before
[19, 20]. Noteworthy, treating the diketone with 15 eq CaCl2 inmethanol
and traces of water yielded compound 5 and traces of 4. In contrast,
repeating the original reaction with distilled instead of crude dichloro-
methane did not give any chlorinated products, but instead aFigure 5. Structure of dichlorodiketone.
3
methoxylated product in low yield was obtained. The above experiments
led us to exclude hypothesis 1 and conclude that the reported chlorina-
tion reaction mechanism proceeds via a different mechanism in which
the less reactive PhI(OAc)Cl intermediate is the possible chlorinating
agent which may only react at high concentrations. To verify the most
reasonable mechanistic pathway, extra ideas and experiments were
tested. The trapping method for the chloronium ion was one of the ideas.
But, applying this idea was not helpful, since the chloronium ion will be
formed in several suggested routes. Alternatively, the substitution reac-
tion was tested against the oxidation reaction of the Cl ions. However,
treating Cl ions from CaCl2 source in MeOH and distilled CH2Cl2 with
PhI(OAc)2 led to the formation of PhICl2 (approved by comparison with
authentic sample) which then reacts directly with the substrate 2 in an
open system leading to the desired products 4 as a major. This makes
route 3 (Scheme 2) as the mechanism of choice.
Due to its symmetry, the tetrachloro derivative 5 only shows half the
set of NMR signals, while the assignment of the unsymmetrical com-
pounds 4 provide individual signals with distinct chemical shifts for all
protons.
As this method of chlorination does not require chlorine gas, it may
become a useful method for chlorination reactions. Moreover, the gen-
eration of defined amounts of chlorine is much easier. Chemically,
compound 5 failed to undergo oxime formation or reduction mediated by
sodium borohydride. These results led us to conclude that, the presence
of one chloro group prevents nucleophilic attack on the carbonyl group
and consequently these findings pave the way to conduct important and
useful regioselective transformations with 4. For instance, derivative 4
regioselectively reacts with sodium borohydride to give 6 as a single
product. This derivative also underwent oxime formation to furnish new
cephalostatin derivative 8 in good yields (Scheme 3). In both cases, only
the carbonyl group reacted that is located in the “chlorine-free hemi-
sphere. However, upon the exposure of excess ylid to a solution of
compound 4, Wittig-reaction seems to be problematic, since it led to
multicomponent products and hence it does not lead to a reproducible
yield of the desired methylenated product. But, still the bis-olefine
product was absent. This was concluded basing on the mass analysis of
the resulted products-mixture. In contrast, using a stoichiometric amount
of the ylid yielded the desired methylenated product in fair to good yield.
Additionally, we studied the reactivity of the “monomeric” precursor of
cephalostatin 9 under the chlorinating conditions described above.
Gratifyingly again a dichlorinated adduct 10 was formed as a single
isomer (Scheme 4). In this case, the reagent diacetoxy iodobenzeneFigure 6. Some interested chlorinated-methoxylated analogues.
M. Nawasreh et al. Heliyon 6 (2020) e03025played a twofold role. It serves as a source for chlorine as described above
and it promotes the established α-methoxylation of a carbonyl group,
leaving position-11 unaltered. The α-configuration of the methoxy group
was determined from the NOESY spectrum which showed a cross peak
between the 2-H proton resonating at 2.95 ppm and the methyl protons
of C-19 resonating at 0.77 ppm.
As an additional support, we were able to successfully dechlorinate
compound 4 and collect cephalostatin derivative 2 in about 65% yield
upon refluxing of 4 in a solution of dichloromethane and acetic acid (1:1)
for 1.5 h in the presence of Zn powder. This is an important finding as the
introduction of the two chlorine atoms serve to desymmetrize symmetric
cephalostatin and after selectively altering the other hemisphere one can
remove them again. Hence, the chlorination can be regarded as pro-
tecting group strategy for asymmetric cephalostatins. The structure of the
product has been approved from spectroscopic data and by comparison
with authentic sample. This reaction broadened the margin of freedom
by enabling us to deprotect the double bond keeping the carbonyl pro-
tected by its neighboring methoxy group.
Furthermore, to understand the effect of chloro groups on the
chemistry of the steroidal backbone especially the chemo selectivity of
the upcoming F-ring opening reaction, an attempt aimed at the synthesis
of symmetrical bis-steroid 5 from 2 found to give in addition to the
desired product a small amount of a less polar side-product, when excess
reagents (10 eq) was used (Scheme 5). Spectral inspection of the side-
product 11 indicated that both chlorination and α-methoxylation took
place.
To explain the formation of the side-product 11 and to understand
more about controlling aspects and favorability/priority of bothScheme 2. Suggested mech
4
processes, two attempts were designed. In the first, the dimer 5 was
tested for methoxylation process however, in the second compound 3D
was tested for chlorination. Compound 5 failed to give 11 as a major
upon exerting a methoxylation conditions using excess reagents (Scheme
6) and instead a multi-component product was obtained. In contrast, the
bis-methoxy derivative 3D, which was synthesized before using a
straightforward procedure [12], underwent chlorination reaction easily
and compound 11 was obtained as a major product in addition to little
amount of the unsymmetrical derivative 12 along with small amount of
the unconverted starting material (Scheme 7). This led us to a conclusion
that the methoxylation process occurs prior the chlorination process.
Additionally, the masked carbonyl with α-methoxy group may not be
involved in the mechanism of chlorination and hence the reagent attacks
from β-face rather than α-face. Moreover, the double bond in the
methoxylated analogue is more labeled toward electrophile than the
unmethoxylated dimer. This was also noticed before toward borane
electrophile in which a hydroboration of Δ14,15 bond in the methoxy-half
was predominant over the unmethoxylated half [17]. This result may be
devised to synthesize an analogue as 13 selectively. Therefore, these
directing groups (methoxy and chloro groups) are used in the designed
strategy.
Even the same reagents were used in both processes, the difference
between chlorination/methoxylation reaction depends on technical
and tactical aspects like temperature-time variations. For the
methoxylation reaction, the reaction temperature should not exceed
10–15 min at 0 C after addition of PhI(OAc)2. However, for the
chlorination reaction the temperature should be kept at 0 C not less
than 5 h after the exposure of the reagent. Noteworthy, the TLC follow-anism of chlorination.
Scheme 3. Regioselective reactions in the chlorine-free hemisphere of the cephalostatin derivative 4.
M. Nawasreh et al. Heliyon 6 (2020) e03025up showed no change on the starting material during the chlorination
reaction until solvent removal. However, after solvent evaporation
under light vacuum and final drying in high vacuum, TLC-analysis
revealed that the product spots could only be detected at this stage
of workup, which contrasts the methoxylation reaction, that could
easily be monitored. Noteworthy, it was noticed that the chlorination
reaction was succeeded when chloroform was used instead of
dichloromethane.
Efforts will be directed towards discovering chemo- and regiose-
lective transformations of analogues such as 4, 12 and 13 (Figures 5
and 6). Ultimately, we hope to unfold numerous opportunities to
further develop the symmetrical concept towards at least one of the
cephalostatins, or very close analogue(s).Scheme 4. Application of the chlorination method to
5
Noteworthy, compounds 4, 5, 6, 8, and 10 were tested against three
cancer cell lines HMO2 (stomach cancer), MCF 7 (breast cancer) and
HEGP (hepatocellular adenocarcinoma) but they didn't show any sig-
nificant activity (GI50  10 μM). This insignificant biological activity
may be rationalized basing on the following suggested reasons. First, the
negative role played by the chloro groups on blocking the neighbouring
carbonyl from certain enzymatic nucleophilic attacks. Second, the chloro
groups reduce the polarity of the substrate resulting in solubility diffi-
culties. Third, the geometrical shape of the molecule will be changed due
to the crucial role played by the double bond. Moreover, and according to
previous studies, the double bond itself played an important positive role
in biological activity of cephalostatins [21].a monosteroidal precursor of the cephalostatins.
Scheme 5. Chlorination and methoxylation of the diketone 2.
Scheme 6. Methoxylation test of compound 5.
Scheme 7. Chlorination of the bis-methoxy derivative 3B.
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Having demonstrated the ability of using the symmetrical coupling
method as alternative to the unsymmetrical one used in total synthesis,
we are report on two new important aspects in the chemistry of the
cephalostatins. First, we demonstrated that it is possible to protect both
the carbonyl and Δ14,15 double groups in one step and which allows to6
flexibly derivatize the unmasked hemisphere. The regioselective
desymmetrization can be utilized to design synthetic strategies towards
important analogs or the natural product that initially rely on symmet-
rical precursors. Secondly, the reagent system for chlorination is new and
the chlorination method is a remarkable, since chlorination of olefinic
double bonds can be conducted without the use of toxic chlorine gas.
Moreover, one can use the easily prepared dichloroiodobenzene to ach-
ieve the desired chlorinated products as 4 and 5. Introduction of a multi-
purpose directing groups as methoxy and chloro groups, which in some
cases is/are more useful than reagents, serves our new methodology to
mimic total synthesis of cephalostatins.
4. Experimental
Notice that, selected spectral data of the following compounds is
attached as a supplementary material.
4.1. General
1H-NMR and 13C-NMR spectra were carried out using the instruments
Brucker AVS 400 (400 MHz, Avance) and AVS 500 (500 MHz, Avance).
The measurements were taken using deuterated solvents and tetrame-
thylsilane or solvent peak as a reference. Peaks in the region (0.7–2.0
ppm), which corresponds to the aliphatic region, will not be assigned
except for the methyl groups and in few cases 9-H.
FAB-MS spectra were carried out using the VG-Autospec in a low
resolution measurement in which the Nitrobenzyl Alcohol Matrix (NBA-
Matrix) was used.
HR-FABMS spectral were carried out using the VG-Autospec in which
the peak-matching method and the NBA-Matrix were used.
Thin Layer Chromatography (TLC) was carried out using aluminum
TLC coated with the silica gel 60F254 from (Merck) combined with the
polygram® Alox N/UV254 Macherey-Nagel. The detection of spots in
TLC was done with the help of a UV-lamp (λ¼ 254 nm) and development
in Ce(IV) sulphate reagent.
Preparative Column Chromatography was carried out using the flash
chromatography principle.
Silica gel used was from Baker (0.03–0.06 mm). Elution was carried
out under a light pressure achieved by the use of a hand pump.
Solvents used are commercial solvents after fractional distillation. In
other cases, dry solvents were used.
Chemicals used have not been further purified. The organometallic
reagents were handled under absolute conditions.
4.2. Preparation methods and spectral data
4.2.1. Preparation of 14β,15α-dichlorodiketone 4 (C54H72N2O6Cl2)
A solution of KOH (0.115 g, 2.0536 mmol) in 4.0 ml MeOH in a well
dried round bottom flask was cooled to 0 C, before a solution of diketone
2 (0.456 g, 0.5396 mmol, 1 eq dissolved in 3 ml of undistilled CH2Cl2)
was added dropwise under argon. The reaction mixture was stirred for 20
min at 0 C followed by a portion-wise addition of diacetoxy iodobenzene
(0.273 g, 0.848 mmol, 1.6 eq). The solution was stirred for additional 4 h
at 0 C and then for 24 h at RT. After the removal of the solvent and
drying under vacuum the crude yellowish material was subjected to silica
gel column chromatography (eluant: EtOAc/hexane ¼ 1:4) yielding
14β,15α-dichlorodiketone 4 as a light-yellow solid (155 mg, 31%) the
symmetrical tetrachloro derivative 5 (52 mg) as amorphous and 190 mg
of the starting material.
IR: CHCl3/vmax/cm1: 2960 s (C–H), 2932 s (C–H), 1712 s (C¼O),
1644 w (C¼C), 1456 m (C–H), 1400 m (pyrazine), 1292 m (C–O), 612 m
(C–Cl). LC-MS (ESI): 915.4753 (Mþ1, 35%). HR-MS: calculated: [M þ
H]þ ¼ 915.48402, found: 915.4846. 1H-NMR: (400 MHz, CDCl3); δ ¼
5.45 (br s, 1H, 150-H), 4.75 (dd, J16-17¼ 8.1 Hz, J16-15¼ 2.0 Hz, 1H, 160-
H), 4.62 (s, 1H, 15-H), 4.46 (d, J16-17 ¼ 6.6 Hz, 1H, 16-H), 3.67 (tr, J17-16
¼ 6.8 Hz, 1H, 17-H), 3.52 (m, 2H, 26a/260a-H), 3.33–3.45 (m, 3H, 26b/
M. Nawasreh et al. Heliyon 6 (2020) e03025260b/170-H), 2.58–2.92 (m, 7H, 1a/10a/4a/40a/4b/40b/110a-H),
2.42–2.56 (m, 7H, 11a/1b/10b/11b/110b/5/50-H), 2.31 (m, 2H, 8/20-H),
2.06 (m, 1H, 80-H), 1.41 (s, 3H, 18-H), 1.30 (s, 3H, 180-H), 1.01 (d, J21-20
¼ 6.8 Hz, 3H, 21-H), 0.97 (d, J21-20¼ 6.7 Hz, 3H, 210-H), 0.89 (s, 3H, 190-
H), 0.84 (s, 3H, 19-H), 0.77 (2d, J27-25 ¼ J27-25¼ 6.2 Hz, 6H, 27/270-H).
13C-NMR: (100 MHz, CDCl3); δ ¼ 210.69 (C, 120-C), 209.07 (C, 12-C),
154.25 (C, 140-C), 148.27,148.25, 148.19, 148.12 (all C, pyrazine-C),
121.56 (CH, 150-C), 107.01 (2C, 22/220-C), 89.91 (C, 14-C), 88.07 (CH,
16-C), 83.87 (CH, 160-C), 68.2 (CH, 15-C), 67.10 (2xCH2, 26/260-C),
62.26 (C, 130-C), 61.83 (C, 13-C), 53.03 (CH, 90-C), 50.32 (CH, 17-C),
49.68 (CH, 170-C), 48.55 (CH, 11-C), 45.21 (CH), 45.06 (2xCH2, 1/10-
C), 44.34 (CH), 44.15 (CH), 41.41 (CH, 20-C), 41.15 (CH, 200-C), 38.68
(CH), 37.14 (CH2, 110-C), 37.14 (C, 10-C), 36.29 (C, 100-C)), 35.35 (CH2,
4-C), 35.02 (CH2, 40-C), 33.89 (CH, 50-C), 31.20 (CH2), 31.03 (CH2),
30.31 (C) 30.26 (CH), 30.06 (CH), 29.07 (CH2), 28.68 (2xCH2), 28.53
(CH2), 27.77 (CH2), 26.54 (CH2), 20.75 (CH3, 180-C), 19.21 (CH3, 18-C),
17.00, 17.07 (2xCH3, 27/270-C), 14.27 (CH3, 21-C), 13.70 (CH3, 210-C),
11.51 (CH3, 190-C), 10.63 (CH3, 19-C).
4.2.2. Tetrachlorodiketone 5 (C54H72N2O6Cl4)
FAB-MS (NBA-matrix): m/z (%): 988 [MH]þ (100%). HR-MS [M þ
H]þ calculated: 985.4223 found 985.4227. 1H-NMR (400MHz, CDCl3); δ
¼ 4.65 (s, 1H, 15-H), 4.49 (d, J16-17 ¼ 8.3 Hz, 1H, 16-H), 3.37 (pseudo tr,
J17-16 J17-20¼ 8.6, 1H, 17-H), 3.51 (dd, J26a-26b¼ 11.4 Hz, J26a-25¼ 3.8
Hz, 1H, 26a-H), 3.37 (pseudo tr, J26b-26a  J26b-25 ¼ 11.2 Hz, 1H, 26b-H),
2.85 (dd, J4a-4b ¼ 17.6 Hz, J4a-5 ¼ 5.1 Hz, 1H, 4a-H), 2.76 (br d, J1a-1b ¼
16.4 Hz, 1H, 1a-H), 2.51–2.68 (m, 5H, 1b/4b/7a/7b/8-H), 2.47 (br d,
J11a-9¼ 11.2, 1H, 11a-H), 2.29–2.39 (m, 2H, 20/9-H), 1.43 (s, 3H, 18-H),
0.99 (d, J21-20 ¼ 6.8 Hz, 3H, 21-H), 0.86 (s, 3H, 19-H), 0.79 (d, J27-25 ¼
6.4 Hz, 3H, 27-H). 13C-NMR (100MHz, CDCl3); δ ¼ 209.1 (C, 12-C),
148.2, 148.1 (both C, pyrazine-C), 107.1 (C, 22-C), 90.0 (C, 14-C),
88.1 (CH, 16-C), 68.2 (CH, 15-C), 67.1 (CH2, 26-C), 61.9 (C, 13-C),
50.4 (CH, 17-C), 48.6 (CH, 8-C), 45.2 (CH2, 1-C), 45.3 (CH), 44.4
(CH), 41.4 (CH, 5-C), 37.1 (C, 10-C), 35.4 (CH2), 35.1 (CH2, 4-C), 31.1
(CH2), 30.1 (CH), 28.7 (CH2), 28.6 (CH2), 26.6 (CH2, 11-C), 19.2 (CH3,
18-C), 17.1 (CH3, 27-C), 14.1 (CH3, 21-C), 10.7 (CH3, 19-C).
4.2.3. Preparation of 120β-hydroxy-14β,15α-dichloroketone 6
(C54H74N2O6Cl2)
To a solution of the dichlorodiketone 4 (130 mg, 0.142 mmol; 1 eq),
dissolved in 4 ml abs. MeOH and 4 ml abs. CH2Cl2 at -78 C, NaBH4 (30
mg, 1.111 mmol, 8 eq.) was added in three portions under argon atmo-
sphere. The reaction mixture was stirred for 30 min to give a single, more
polar product as judged by tlc. The reaction was terminated by addition
of 1 ml of acetaldehyde before extraction was conducted using a satu-
rated ammonium chloride solution. The aqueous phase was further
extracted with chloroform and the the combined organic extracts were
removed under reduced pressure. The resulting crude material was pu-
rified by column chromatography using a silica gel column chromatog-
raphy which yielded dichlorohydroxy ketone 6 (110 mg, 85%) as a pale-
yellow solid material.
HR-MS: [MþH]þ calculated: 917.49967, found: 917.5159. 1H-NMR:
(400 MHz, CDCl3); δ ¼ 5.45 (br s, 1H, 150-H), 4.85 (dd, J16-17¼ 8.3 Hz,
J16-15¼ 1.4 Hz, 1H, 160-H), 4.62 (s, 1H, 15-H), 4.46 (d, J16-17 ¼ 6.6 Hz,
1H, 16-H), 3.67 (tr, J17-16 ¼ 6.8 Hz, 1H, 17-H), 3.31–3.51 (m, 4H, 26a/
260a/26b/260b-H), 3.24 (dd, J12-11a ¼ 11.2 Hz, J12-11b ¼ 4.6 Hz, 1H, 120-
H), 2.71–2.90 (m, 4H, 1a/10a/4a/40a-H), 2.42–2.65 (m, 8H, 1b/10b/4b/
40b/5/11a/11b/170-H), 2.33 (m, 2H, 8/20-H), 1.41 (s, 3H, 18-H), 1.03
(d, J21-20¼ 6.8 Hz, 3H, 210-H), 1.01 (s, 3H, 180-H), 0.97 (d, J21-20 ¼ 6.8
Hz, 3H, 21-H), 0.85, 0.84 (both s, 6H, 19/190-H) 0.77, 0.78 (2d, J27-25 ¼
J27-25¼ 6.2 Hz, 6H, 27/270-H). 13C-NMR: (100 MHz, CDCl3); δ ¼ 209.07
(C, 12-C), 157.22 (C, 140-C), 148.61, 148.62, 147.92, 147.93, 147.98
(4C, pyrazine-C), 119.68 (CH, 150-C), 107.01 (C, 22-C), 106.75 (C, 220-
C), 89.94 (C, 14-C), 88.07 (CH, 16-C), 84.55 (CH, 160-C), 78.84 (CH, 120-
C), 68.2 (CH, 15-C), 67.11 (2xCH2, 26/260-C), 61.83 (C, 13-C), 55.92
(CH, 170-C), 52.71 (C, 130-C), 50.29 (CH, 17-C), 52.12 (CH, 90-C), 50.037
(CH, 17-C), 48.55 (CH) 45.47, 45.05 (2xCH2, 1/10-C), 45.19 (CH), 44.38,
44.32 (2xCH), 41.41, 41.38 (2xCH), 37.03 (CH), 35.95 (C, 100-C), 35.34
(CH2), 35.22 (CH2, 40-C), 35.03 (CH2, 4-C), 33.62 (CH), 31.08 (CH2),
31.03 (CH2), 30.31 (CH), 30.04 (CH), 29.88 (CH2), 29.09 (CH2), 28.74
(CH2), 28.68 (CH2), 27.96 (CH2), 26.54 (CH2), 19.15 (CH3, 18-C), 17.09
(2xCH3, 27/270-C), 14.27 (CH3, 21-C), 13.81 (CH3, 210-C), 13.28 CH3,
180-C), 11.78 (CH3, 190-C), 10.63 (CH3, 19-C).
4.2.4. Preparation and spectral data of monoxime derivative 8
In a clean and dry 10-mL RBF, 8 mg (8.7 μmol, 1 eq) of compound 4
and 5 mg (71.9 μmol, 8.3 eq) were dissolved in 2 mL of Pyridine/Ethanol
(1:1) mixture and stirred at rt overnight. After the reaction completion
(TLC follow) which showed a complete conversion of the starting ma-
terial, the turbid solution was quenched by the addition of 2 mL dis.
water. The reaction solution was extracted with dichloromethane twice
and the combined organic phase was extracted with 2 M solution of
oxalic acid. The organic phase was dried in the fumehood at 50 C to
remove the pyridine rest. The resulted dry crude material was chroma-
tographed on silica-gel column using EtOAc/PE (1:2) eluent yielded 7 mg
of 8 as a pure pale-yellow solid material (87% yield).
IR: (KBr/vmax/cm1); 3600 br (O–H), 2948 s (C–H), 1656 w (C¼C),
1636 w (C¼N), 1448 s (C–H), 1396 s (pyrazine), 1240 s (C–O), 618 m
(C–Cl). HR-MS: [M þ H]þ calculated: 930.494919, found: 930.4955.
1H-NMR: (600 MHz, CDCl3); δ¼ 5.45 (br s, 1H, 150-H), 4.85 (dd, J16'-
15' ¼ 8.3 Hz, J16'-17' ¼ 1.6 Hz, 1H, 160-H), 4.68 (s, 1H, 15-H), 4.52 (d, J16-
17 ¼ 8.3 Hz, 1H, 16-H), 3.35–3.85 (m, 8H, 17/17'/110a/110b/26a/26b/
260a/260b-H), 1.46 (s, 3H, 18-H), 1.29 (s, 3H, 180-H), 1.09 (d, J21'-20' ¼
6.8 Hz, 3H, 210-H), 1.01 (d, J21-20 ¼ 6.8 Hz, 3H, 21-H), 0.83 (2d, 6H, 27/
270-H).
13C-NMR: (150 MHz, CDCl3); δ ¼ 209.1 (C, 12-C), 162.2 (C, 120-C),
157.3 (C, 140-C), 148.8, 148.4, 147.2, 146.8 (all C, pyrazine-C), 119.9
(CH, 150-C), 107.2, 107.1 (both C, 22/220-C), 90.0 (C, 14-C), 88.1 (CH,
16-C), 84.3 (CH, 160-C), 68.3 (CH, 15-C), 67.1 (2xCH2, 26-C), 61.9 (C, 13-
C), 53.5 (C, 130-C), 52.7 (CH, 90-C), 50.9, 50.4 (both CH, 17/170-C), 48.6
(CH), 45.3, 44.4 (both CH2, 1/10-C), 44.3 (CH), 41.5 (CH), 41.4 (CH),
37.1, 36.1 (both C, 10/100-C), 35.4, 35.2 (both CH2, 4/40-C), 35.0 (CH2),
34.2 (CH) 31.9 (CH), 31.5(CH2), 31.4 (CH2), 31.1 (CH2), 30.4 (CH), 30.2
(CH), 30.1 (CH), 29.4 (CH2), 29.2 (CH2), 28.8 (CH2), 28.5 (CH2), 27.8
(CH2), 26.6 (CH2), 22.7 (CH3,180-C), 19.2 (CH3, 18-C), 17.2 (CH3, 27-C),
14.4 (CH3, 270-C), 14.1,13.9 (both CH3, 21/210-C), 11.5, 10.8 (both CH3,
19/190-C).
4.2.5. Preparation of 2α-methoxy-14β,15α-dichlorodione 10
(C28H40O5Cl2)
To an icy cold solution of KOH (0.63 g, 11.4286 mmol, 9.7 eq.) dis-
solved in 5 ml MeOH in a dry 100 ml round bottom flask under argon
atmosphere a solution of the dione 10 (0.5 g, 1.174 mmol, 1 eq.) dis-
solved in 5 ml of undistilled CH2Cl2 was added dropwise and the reaction
mixture was stirred for 20 min. Diacetoxy iodosobenzene (2.55 g, 7.919
mmol, 6.8 eq) was added portion-wise to the reaction mixture and stir-
ring was continued for 2 h at 0 C and for 24 h at RT. After removal of the
solvent under reduced pressure and complete drying under high vacuum
the resulting crude material was subjected to a silica gel column chro-
matography (eluted with 10% EtOAc:PE) which yielded 3α-methoxy-
14β,15α-dichlorodione 11 (170 mg), 27.5%) as a brownish yellow solid
(27.5 %) along with 95 mg of the starting material.
IR: CHCl3/vmax/cm1: 2980, 2869 s (C–H), 1717 s (C¼O), 1454 m
(C–H), 1170 s (C–O), 620 m (C–Cl). EI-MS: m/z (%); 526 (7%) [M]þ, 491
(10%) [M-Cl]þ, 458 (17%), 419 (9%), 377 (23%), 341 (52%). 126
(100%).HR-MS: [MþH]þ calculated: 527.232556, found 527.2331. 1H-
NMR: (400 MHz, CDCl3); δ ¼ 4.64 (s, 1H, 15-H), 4.49 (d, J ¼ 8.3 Hz, 1H,
16-H), 3.68 (tr, J ¼ 5.9 Hz, 1H, 17-H), 3.67 (s, 3H, 28-H), 3.49 (m, 1H,
26a-H), 3.36 (m, 1H, 26b-H), 2.95 (m, 1H, 2-H), 1.41 (s, 3H, 18-H), 0.97
(d, J ¼ 6.9 Hz, 3H, 21-H), 0.78 (d, J¼ 6.4 Hz, 3H, 27-H), 0.77 (s, 3H, 19-
H).13C-NMR: (100 MHz, CDCl3); δ ¼ 208.94 (C, 12-C), 177.23 (C, 3-C),
106.92 (C, 22-C), 90.30 (C, 14-C), 88.35 (CH, 16-C), 68.08 (CH, 15-C),
M. Nawasreh et al. Heliyon 6 (2020) e0302567.02 (CH2, 26-C), 62.28 (C, 13-C), 51.79 (CH3, 28-C), 50.08 (CH, 17-C),
49.52 (CH), 48.77 (CH), 45.31 (CH), 45.18 (C, 10-C), 44.78 (CH), 43.03
(CH2), 39.98 (CH, 2-C), 37.33 (CH2), 31.56 (CH2), 31.02 (CH2), 30.07
(CH), 28.69 (CH2), 26.99 (CH2), 26.87 (CH2), 19.53 (CH3, 18-C), 17.10
(CH3, 27-C), 14.30 (CH3, 21-C), 11.73 (CH3, 19-C).
4.2.6. Spectral data of compound 11 (C56H76N2O8Cl4)
IR: (CHCl3/vmax/cm1); 2956, 2932 both s (C–H), 1732 s (C¼O),
1456 s (C–H), 1400 m (pyrazine), 1320, 1280 both s (C–O), 860, 896
both m(C–Cl). FAB-MS: (NBA-Matrix): m/z (%); 1048 [MHþ] (100 %).
HR-FAB-MS: calculated: 1047.02324, found: 1047.02308. 1H-NMR:
(400 MHz, CDCl3): δ ¼ 4.27 (m, 1H, 16-H), 4.13 (m, 1H, 15-H), 3.78 (s,
3H, 28-H), 4.23–4.31 (m, 1H, 26a-H), 4.08–4.16 (m, 1H, 26b-H), 3.21
(m, 1H, 17-H), 2.75–2.90 (m, 2H, 1a/4a-H), 2.40–2.65 (m, 5H, 1b/4b/5/
8/11-H), 1.96 (tr, J9-11 ¼ J9-8 ¼ 12.3 Hz,1H, 9-H), 1.31 (s, 3H, 18-H),
0.85 (d, J21-20 ¼ 6.4 Hz, 3H, 21-H),0.80 (d, J27-25 ¼ 5.7 Hz, 27-H),
0.79 (s, 3H, 19-H). 13C-NMR: (100MHz, CDCl3) δ ¼ 172.70 (C, 12-C),
148.31, 147.88 (both C, pyrazin-C), 108.33 (C, 22-C), 85.25 (C-14-C),
81.52 (CH, 16-C), 72.28 (CH, 15-C), 67.38 (CH2, 26-C), 55.06 (C, 13-C),
54.70 (CH), 54.36 (CH, 9-C), 53.85 (CH), 52.02 (CH3, 28-C), 48.97 (CH,
17-C), 46.02 (CH2, 1-C), 45.00 (CH), 40.67 (CH), 37.04 (C, 10-C), 34.67
(CH2, 4-C), 31.71 (CH2), 30.33(CH), 29.92 (CH2), 28.26 (CH2), 27.95
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